Botulin injection vs. tibial nerve neurotomy for the treatment of spastic equinovarus foot .
This report has been verified
by one or more authors of the
original publication.
A randomized controlled trial of selective neurotomy versus botulinum toxin for spastic equinovarus foot after stroke
Neurorehabil Neural Repair. 2013 Oct;27(8):695-70316 patients who experienced spastic hemiparesis secondary to stroke and spastic equinovarus of the foot (SEF) due to over activity of the calf muscle, were randomly assigned into 1 of 2 treatment groups to determine if tibial nerve neurotomy (TNN) was as effective as botulin toxin injections in the treatment of spastic equinovarus of the foot in terms of body function and structure domain, activity, participation, and quality of life. Results of the study indicated that TNN lead to a higher reduction in ankle stiffness following treatment. However, both treatments lead to comparable improvements in ankle kinematics during gait, and neither induced muscle weakening following intervention. Activity, participation, and quality of life did not change in either group during the treatment/ follow-up period.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
